Literature DB >> 9634512

Evidence for linkage of human primary systemic carnitine deficiency with D5S436: a novel gene locus on chromosome 5q.

Y Shoji1, A Koizumi, T Kayo, T Ohata, T Takahashi, K Harada, G Takada.   

Abstract

Primary systemic carnitine deficiency (SCD) is a rare hereditary disorder transmitted by an autosomal recessive mode of inheritance. The disorder includes cardiomyopathy, muscle weakness, hypoketotic coma with hypoglycemia, and hyperammonemia. In this study, we conducted a linkage analysis of a Japanese SCD family with a proband-a 9-year-old girl-and 26 members. The serum and urinary carnitine levels were determined for all members. The entire genome was searched for linkage to the gene locus for SCD, by use of a total of approximately 300 polymorphic markers located approximately 15-20 cM apart. In the family, there were two significantly different phenotypes, in terms of serum free-carnitine levels: low serum free-carnitine level (29.5+/-5.0 microM; n=14) and normal serum free-carnitine level (46.8+/-6.2 microM; n=12). There was no correlation of urinary free-carnitine levels with the low serum-level phenotype (putative heterozygote), but in normal phenotypes (wild type) urinary levels decreased as the serum levels decreased; renal resorption of free carnitine appeared to be complete in wild-type individuals, when the serum free-carnitine level was <36 microM. Linkage analysis using an autosomal dominant mode of inheritance of heterozygosity revealed a tight linkage between the disease allele and D5S436 on chromosome 5q, with a two-point LOD score of 4.98 and a multipoint LOD score of 5.52. The haplotype analysis revealed that the responsible genetic locus lies between D5S658 and D5S434, which we named the "SCD" locus. This region was syntenic with the jvs locus, which is responsible for murine SCD. Phylogenic conversion of the SCD locus strongly suggests involvement of a single gene, in human SCD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9634512      PMCID: PMC1377235          DOI: 10.1086/301911

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  13 in total

Review 1.  Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy.

Authors:  I Tein; D C De Vivo; F Bierman; P Pulver; L J De Meirleir; L Cvitanovic-Sojat; R A Pagon; E Bertini; C Dionisi-Vici; S Servidei
Journal:  Pediatr Res       Date:  1990-09       Impact factor: 3.756

2.  Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects.

Authors:  T A Golper; M Wolfson; S Ahmad; R Hirschberg; P Kurtin; L A Katz; R Nicora; D Ashbrook; J D Kopple
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

3.  Mapping of jvs (juvenile visceral steatosis) gene, which causes systemic carnitine deficiency in mice, on chromosome 11.

Authors:  H Nikaido; M Horiuchi; N Hashimoto; T Saheki; J Hayakawa
Journal:  Mamm Genome       Date:  1995-05       Impact factor: 2.957

4.  Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy.

Authors:  M E Tripp; M L Katcher; H A Peters; E F Gilbert; S Arya; R J Hodach; A L Shug
Journal:  N Engl J Med       Date:  1981-08-13       Impact factor: 91.245

5.  Infantile disease with microvesicular fatty infiltration of viscera spontaneously occurring in the C3H-H-2(0) strain of mouse with similarities to Reye's syndrome.

Authors:  T Koizumi; H Nikaido; J Hayakawa; A Nonomura; T Yoneda
Journal:  Lab Anim       Date:  1988-01       Impact factor: 2.471

6.  Primary carnitine deficiency: heterozygote and intrafamilial phenotypic variation.

Authors:  B Garavaglia; G Uziel; F Dworzak; F Carrara; S DiDonato
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

7.  Carnitine determination by an enzymatic cycling method with carnitine dehydrogenase.

Authors:  M Takahashi; S Ueda; H Misaki; N Sugiyama; K Matsumoto; N Matsuo; S Murao
Journal:  Clin Chem       Date:  1994-05       Impact factor: 8.327

8.  Primary systemic carnitine deficiency. II. Renal handling of carnitine.

Authors:  A G Engel; C J Rebouche; D M Wilson; A M Glasgow; C A Romshe; R P Cruse
Journal:  Neurology       Date:  1981-07       Impact factor: 9.910

Review 9.  Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake.

Authors:  C A Stanley; S DeLeeuw; P M Coates; C Vianey-Liaud; P Divry; J P Bonnefont; J M Saudubray; M Haymond; F K Trefz; G N Breningstall
Journal:  Ann Neurol       Date:  1991-11       Impact factor: 10.422

10.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more
  10 in total

1.  Carnitine levels in skeletal muscle, blood, and urine in patients with primary carnitine deficiency during intermission of L-carnitine supplementation.

Authors:  J Rasmussen; J A Thomsen; J H Olesen; T M Lund; M Mohr; J Clementsen; O W Nielsen; A M Lund
Journal:  JIMD Rep       Date:  2015-02-10

Review 2.  Carnitine biosynthesis in mammals.

Authors:  Frédéric M Vaz; Ronald J A Wanders
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

3.  Multiple acyl-CoA dehydrogenation deficiency as decreased acyl-carnitine profile in serum.

Authors:  Bing Wen; Duoling Li; Wei Li; Yuying Zhao; Chuanzhu Yan
Journal:  Neurol Sci       Date:  2015-04-01       Impact factor: 3.307

4.  SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).

Authors:  Chunyu Wang; Ivan P Uray; Abhijit Mazumdar; Julie Ann Mayer; Powel H Brown
Journal:  Breast Cancer Res Treat       Date:  2012-01-03       Impact factor: 4.872

5.  Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.

Authors:  Y Wang; J Ye; V Ganapathy; N Longo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 6.  Defects in activation and transport of fatty acids.

Authors:  M Brivet; A Boutron; A Slama; C Costa; L Thuillier; F Demaugre; D Rabier; J M Saudubray; J P Bonnefont
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 7.  Carnitine transport: pathophysiology and metabolism of known molecular defects.

Authors:  I Tein
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

8.  Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events.

Authors:  Jan Rasmussen; Olav W Nielsen; Allan M Lund; Lars Køber; Høgni Djurhuus
Journal:  J Inherit Metab Dis       Date:  2012-05-08       Impact factor: 4.982

Review 9.  Effects of l-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies.

Authors:  Michele Malaguarnera; Omar Cauli
Journal:  Molecules       Date:  2019-11-22       Impact factor: 4.411

10.  Different involvement of promoter methylation in the expression of organic cation/carnitine transporter 2 (OCTN2) in cancer cell lines.

Authors:  Qiang Qu; Jian Qu; Min Zhan; Lan-Xiang Wu; Yi-Wen Zhang; Xiao-Ya Lou; Li-Juan Fu; Hong-Hao Zhou
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.